JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis

by Leeyen Hsu, April W. Armstrong
Published 2014-01-01

Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

by Balvinder Rehal, April W Armstrong
Published 2011-01-01

Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy.

by Elizabeth A Brezinski, April W Armstrong
Published 2012-01-01

An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.

by Sanminder Singh, Paulina Young, April W Armstrong
Published 2017-01-01

Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study

by Nicole Salame, Nazanin Ehsani-Chimeh, April W. Armstrong
Published 2019-02-01

Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success

by April W. Armstrong, Weily Soong, Jonathan A. Bernstein
Published 2023-06-01

Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011.

by April W Armstrong, Clayton Schupp, Julie Wu, Bruce Bebo
Published 2012-01-01

Pemphigus and bullous pemphigoid in the United States: a 21-year analysis of patient characteristics, treatment patterns, and comorbidities

by Yasmin Gutierrez, Sarah P. Pourali, Indira Singh, April W. Armstrong
Published 2022-05-01

Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States

by Khoa Nguyen, Nazanin Ehsani-Chimeh, Nicole Salame, April W. Armstrong
Published 2021-05-01

Are patients comprehending? A critical assessment of online patient educational materials

by Thanh-Lan Bui, Catalina Silva-Hirschberg, Josefina Torres, April W. Armstrong
Published 2018-04-01

Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States

by Jashin J. Wu, Karen A. Veverka, Minyi Lu, April W. Armstrong
Published 2019-07-01

Association between atopic dermatitis and conjunctivitis in adults: a population-based study in the United States

by Kevin K. Wu, Andrea J. Borba, Pierce H. Deng, April W. Armstrong
Published 2021-05-01

Does location matter? Geographic variations in healthcare resource use for atopic dermatitis in the United States

by Kevin K. Wu, Khoa B. Nguyen, Jeena K. Sandhu, April W. Armstrong
Published 2021-04-01

Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists.

by April W Armstrong, Mei W Kwong, Lynda Ledo, Thomas S Nesbitt, Sandra L Shewry
Published 2011-01-01

Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes

by April W. Armstrong, Benjamin Banderas, Catherine Foley, Jonathan Stokes, Murali Sundaram, Alan L. Shields
Published 2017-08-01

Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists

by Kaitlyn M. Yim, Rebecca M. Yim, Sara Gaspard, Jamie MacDougall, April W. Armstrong
Published 2022-04-01

Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis

by Indira Singh, Vipawee S. Chat, Angeline Uy, Andrea Borba, Alice Y. Chen, April W. Armstrong
Published 2022-04-01

Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation

by Ronald Prussick, Jashin J. Wu, April W. Armstrong, Michael P. Siegel, Abby S. Van Voorhees
Published 2018-05-01

Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan

by April W. Armstrong, Yang Zhao, Vivian Herrera, Yunfeng Li, Tim Bancroft, Michael Hull, Aylin Altan
Published 2017-10-01

Language proficiency and biologics access: a population study of psoriasis patients in the United States

by Vipawee S. Chat, Joshua Hekmatjah, Tiffany J. Sierro, Ari A. Kassardjian, Charlotte Read, April W. Armstrong
Published 2022-04-01